Advanced Technologies for Novel Therapeutics LLC (ATNT) is a biotechnology company developing cross-disciplinary engineering methods to find the most effective molecular targets for the treatment of complex human disorders. ATNT has expertise encompassing the fields of molecular biology, cell biology, biochemistry, molecular genetics, human genetics, animal models, systems biology and engineering disciplines. ATNT has successfully developed many novel tools and techniques, to identify the most important therapeutic targets in complex cellular networks. ATNT provides a unique service to pharmaceutical and biotech companies to provide a set of therapeutic targets which have a minimal chance of failure, minimizing the time and cost of finding novel therapeutics. A major obstacle to successful development of novel therapeutics is the toxicity of a compound, generally created because molecules that are targeted by the compound have critical physiological functions. ATNT offers alternative molecular targets that achieve similar functional outcomes without having those side effects.
